The Potential Impact of Preventive HIV Vaccinesin China: Results and Benefits of a Multi-ProvinceModeling Collaboration

Vaccines

Li Liu¹  Liao Feng¹  Zunyou Wu²  Wei Guo²  Joan Kaufman³  John Stover⁴  Thomas Harmon⁵  Bernard Schwartländer⁶  Kammerle Schneider⁷ 

[1] Center for Disease Control and Prevention of Sichuan Province, Chengdu 610041, China;Chinese National Center for AIDS/STD Control and Prevention (NCAIDS), Beijing 102206, China;Columbia University Global Centers, East Asia, Beijing 100080, China;Futures Institute, Glastonbury, CT 06033, USA;International AIDS Vaccine Initiative, 125 Broad St., 9th Floor, New York, NY 10004, USA;Joint United Nations Programme for HIV/AIDS (UNAIDS), Geneva CH-1211, Switzerland;PATH, Seattle, WA 98121, USA;

关键词: HIV/AIDS;    vaccines;    China;    Sichuan;    prevention;    research;    modeling;   

DOI  :  10.3390/vaccines3010001

来源: DOAJ

【 摘 要 】

China’s commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response. This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection. A preventive HIV vaccine would add a powerful tool to China’s response, even if not 100% efficacious or available to the full population.

【 授权许可】

Unknown